A61K 51/1093
Conjugates with carriers being antibodies
Official title: {conjugates with carriers being antibodies}
A61K51/1093 (Conjugates with carriers being antibodies) appears on 691 US grants and 895 published applications in this corpus.
Search patents in A61K- Granted patents
- 691
- Published applications
- 895
- Assignees
- 425
- Inventors
- 1,801
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 18 | 0 |
| 1990 | 13 | 0 |
| 1991 | 22 | 0 |
| 1992 | 32 | 0 |
| 1993 | 25 | 0 |
| 1994 | 21 | 0 |
| 1995 | 17 | 0 |
| 1996 | 19 | 0 |
| 1997 | 27 | 0 |
| 1998 | 21 | 0 |
| 1999 | 11 | 0 |
| 2000 | 11 | 0 |
| 2001 | 10 | 2 |
| 2002 | 11 | 13 |
| 2003 | 5 | 15 |
| 2004 | 9 | 34 |
| 2005 | 3 | 15 |
| 2006 | 11 | 11 |
| 2007 | 7 | 8 |
| 2008 | 11 | 10 |
| 2009 | 6 | 14 |
| 2010 | 5 | 23 |
| 2011 | 7 | 9 |
| 2012 | 11 | 16 |
| 2013 | 15 | 33 |
| 2014 | 14 | 54 |
| 2015 | 34 | 46 |
| 2016 | 34 | 49 |
| 2017 | 29 | 45 |
| 2018 | 29 | 33 |
| 2019 | 23 | 40 |
| 2020 | 20 | 49 |
| 2021 | 19 | 41 |
| 2022 | 27 | 62 |
| 2023 | 23 | 66 |
| 2024 | 21 | 95 |
| 2025 | 30 | 54 |
| 2026 | 20 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Urokinase plasminogen activator receptor-targeted radiopharmaceutical22 Sep 2026US 12,741,039 B2Monopar Therapeutics Inc.
- DR5 radioimmunotherapy in the treatment of solid cancers1 Sep 2026US 12,721,913 B2Actinium Pharmaceuticals, Inc.
- HER3 radioimmunotherapy for the treatment of solid cancers1 Sep 2026US 12,721,915 B2Actinium Pharmaceuticals, Inc.
- Combination therapy for treating cancer25 Aug 2026US 12,714,759 B2City of Hope
- CD8 binding agents and uses thereof25 Aug 2026US 12,715,920 B2Genentech, Inc.
- In vivo imaging of an als biomarker and means therefor8 Oct 2026US 2026/0306683 A1AL-S Pharma AG
- Humanised antibodies and uses thereof24 Sep 2026US 2026/0284244 A1Telix Pharmaceuticals (Innovations) Pty Ltd.
- Anti-bdca2 antibody24 Sep 2026US 2026/0285985 A1Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Crosslinking antibodies10 Sep 2026US 2026/0263646 A1Enlaza Therapeutics, Inc.
- Developing an anti-human cd45 imaging probe for noninvasive detection of human immune cells10 Sep 2026US 2026/0263647 A1Dana-Farber Cancer Institute, Inc.
Most cited
By later US patents
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Tumoricidal methotrexate-antibody conjugate378US 4,699,784 ACenter for Molecular Medicine and Immunology · 1987
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988
- Metal chelate conjugated monoclonal antibodies310US 4,472,509 A1984
- Antibody-therapeutic agent conjugates288US 4,867,973 ACytogen Corporation · 1989